This new Ad Standards Guidance provides a comprehensive framework for navigating environmental advertising in accordance with the Canadian Code of Advertising Standards, emphasizing that while “green” marketing is valuable, […]
Health Canada has finalized its regulatory approach for topical products containing human-derived exosomes, extracellular vesicles, and cell-conditioned media. Rather than labeling these substances as “inherent drugs,” Health Canada has […]
Our April 23, 2025 Regulatory Essentials reported the publication of A Guide to the environmental risk management authorities under the Food and Drugs Act. This guide highlights the principles, […]
March 25, 2026 an order adding 2-ethylhexyl-2-ethylhexanoate (CAS 7425-14-1) to Part 2 of Schedule 1 to the Canadian Environmental Protection Act (CEPA) was published in the Canada Gazette, Part II, Volume […]
On March 24th, an Order Amending the Non-domestic Substances List (NDSL) was published in the Canada Gazette, Part I, Volume 160, Number 14. This order adds 174 substances to the NDSL. […]
As noted in our last Regulatory Essentials, the Government of Canada has amended the Section 46 Notice for the Federal Plastics Registry, postponing reporting deadlines for Phases 2 and […]
Several recent finalized ICH guidelines have been released in the last 12 months. Of importance for the types of products we represent at Cosmetics Alliance are: Q12 Technical […]
The Natural and Non-prescription Health Products Directorate (NNHPD) has launched a dedicated landing page for Non-prescription Drugs (NPDs) to provide clearer guidance for industry stakeholders. Key Highlights: […]
Bill C-15 received Royal Assent on March 26, 2026. Embedded in this budget bill (at section 597 (1), which amends 74.01 (1) (b.2) of the Competition Act) amended […]
Following CA’s Notice to members on March 10, 2026, which outlined Health Canada’s more flexible approach for disclosing fragrance allergen concentrations on the Cosmetic Notification Form (CNF). Under these […]
